Active surveillance of adverse events following COVID-19 vaccines in a tertiary care hospital.

Naveena Mary CherianDravya Anna DuraiMuhammed JaiselDivyansh SharmaJuny SebastianChetak Kadabasal BasavarajaMerrin Mathew

Published in: Therapeutic advances in vaccines and immunotherapy (2023)

have a generally favourable safety profile. However, close monitoring is required to identify the potential signals, as the safety data from the clinical trials are limited.

Keyphrases

clinical trial
coronavirus disease
sars cov
big data
machine learning
risk assessment
phase ii
artificial intelligence
deep learning
data analysis